MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and ...
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European ...
MASON, Ohio - AtriCure, Inc. (NASDAQ: ATRC), a company specializing in medical devices for atrial fibrillation (Afib) and related conditions, has recently obtained regulatory approval to market its ...
New technology combines Pulsed Field Ablation (PFA) and Advanced Radiofrequency Ablation with AtriCure’s EnCompass® clamp to reduce treatment time for surgical ablation patients The new platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results